Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis

被引:11
|
作者
Magro, Fernando [1 ,2 ,3 ,4 ]
Estevinho, Maria Manuela [1 ,5 ]
Dias, Claudia Camila [6 ,7 ]
Correia, Luis [8 ]
Lago, Paula [9 ]
Ministro, Paula [10 ]
Portela, Francisco [11 ]
Feakins, Roger [12 ]
Danese, Silvio [13 ,14 ]
Peyrin-Biroulet, Laurent [15 ,16 ]
机构
[1] Univ Porto, Fac Med, Dept Biomed, Unit Pharmacol & Therapeut, Rua Placido Costa, P-4200450 Porto, Portugal
[2] Sao Joao Hosp Ctr, Dept Gastroenterol, Porto, Portugal
[3] Ctr Drug Discovery & Innovat Med, MedInUP, Porto, Portugal
[4] Sao Joao Hosp Univ Ctr, Clin Pharmacol Unit, Porto, Portugal
[5] Vila Nova Gaia Espinho Hosp Ctr, Dept Gastroenterol, Vila Nova De Gaia, Portugal
[6] Univ Porto, Dept Community Med Informat & Decis Hlth, Fac Med, Porto, Portugal
[7] Ctr Hlth Technol & Serv Res, Porto, Portugal
[8] Univ Lisbon, Santa Maria Hosp, Dept Gastroenterol & Hepatol, Lisbon, Portugal
[9] Porto Hosp Ctr, Dept Gastroenterol, Porto, Portugal
[10] Tondela Viseu Hosp Ctr, Dept Gastroenterol, Viseu, Portugal
[11] Univ Hosp Ctr Coimbra, Dept Gastroenterol, Coimbra, Portugal
[12] Royal Free London NHS Fdn Trust, Dept Histopathol, London, England
[13] Humanitas Clin & Res Ctr IRCCS, IBD Ctr, Dept Gastroenterol, Milan, Italy
[14] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[15] Lorraine Univ, Nancy Univ Hosp, Inst Natl Sante & Rech Med U954, Nancy, Meurthe Moselle, France
[16] Lorraine Univ, Nancy Univ Hosp, Dept Gastroenterol, Nancy, France
来源
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷 / 04期
关键词
Histology; inflammatory bowel disease; treatment outcomes; ulcerative colitis; RELAPSE; REMISSION; THERAPY; MARKERS;
D O I
10.1093/ecco-jcc/jjaa176
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Interest in histology for ulcerative colitis [UC] has increased recently. This systematic review and meta-analysis aims to assess, for the first time, whether histological outcomes are more informative than endoscopic and clinical outcomes in distinguishing the impact of intervention over placebo in induction trials. Methods: MEDLINE, ScienceDirect and Cochrane Central Register of Controlled Trials were searched to identify randomized placebo-controlled trials [RCTs] enrolling moderate-to-severe UC patients. Studies were assessed using the Quality Assessment Tool for Studies with Diverse Designs. We analysed the pooled proportion of patients achieving clinical, endoscopic and histological remission and response after a pharmacological intervention and compared the results with those of placebo-treated patients by using a random-effects model. Results: From 889 identified records, 13 RCTs were included. The odds ratio [OR] for remission was higher in patients receiving intervention than in those under placebo for clinical (OR 2.13, 95% confidence interval [CI] 1.33-3.43), endoscopic [OR 1.46, 95% CI 0.19-11.18] and histological remission [OR 1.85, 95% CI 1.20-2.84]. Significant differences were observed for all response outcomes [clinical: OR 2.27, 95% CI 1.84-2.85; endoscopic: OR 2.16, 95% CI 1.51-3.10; histological: OR 3.63, 95% CI, 1.41-9.36]. No significant heterogeneity existed; no subgroup effects were found for duration of the induction or histological scale [p>0.05]. Clinical and histological remission and endoscopic response were concordant in discriminating interventions from placebo. Conclusion: Histological outcomes are informative in trials of moderate-to-severe UC. Further studies analysing histology at the end of induction are needed to confirm its relevance in distinguishing the efficacy of an intervention over placebo in comparison to clinical and endoscopic outcomes and to explore its prognostic value.
引用
收藏
页码:551 / 566
页数:16
相关论文
共 50 条
  • [21] Systematic review and meta-analysis: Patient-reported outcomes and endoscopic appearance in ulcerative colitis
    Narula, N.
    Alshahrani, A-A.
    Yuan, Y.
    Reinisch, W.
    Colombel, J-F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S195 - S195
  • [22] Comparative efficacy on steroid-free remission of pharmacological therapies for moderate-to-severe ulcerative colitis: A systematic review and network meta-analysis
    Paschos, P.
    Katsoula, A.
    Giouleme, O.
    Tsapas, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S449 - S450
  • [23] Induction and maintenance of clinical remission by adalimumab in patients with moderate-to-severe Ulcerative Colitis
    Sandborn, William
    Van Assche, Gert
    Reinisch, Walter
    Colombel, Jean-Frederic
    D'Haens, Geert
    Wolf, Douglas
    Kron, Martina
    Tighe, Mary
    Lazar, Andreas
    Thakkar, Roopal
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S3 - S4
  • [24] Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life
    Paschos, Paschalis
    Katsoula, Anastasia
    Salanti, Georgia
    Giouleme, Olga
    Athanasiadou, Eleni
    Tsapas, Apostolos
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (11-12) : 1174 - 1185
  • [25] Induction and Maintenance of Clinical Remission by Adalimumab in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Van Assche, Gert A.
    Reinisch, Walter
    Colombel, Jean-Frederic
    D'Haens, Geert R.
    Wolf, Douglas C.
    Kron, Martina
    Tighe, Mary Beth
    Lazar, Andreas
    Thakkar, Roopal
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S123 - S124
  • [26] Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis
    Paschos, P.
    Katsoula, A.
    Giouleme, O.
    Tsapas, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S418 - S419
  • [27] Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis
    Paschos, Paschalis
    Katsoula, Anastasia
    Giouleme, Olga
    Sarigianni, Maria
    Liakos, Aris
    Athanasiadou, Eleni
    Bekiari, Eleni
    Tsapas, Apostolos
    [J]. ANNALS OF GASTROENTEROLOGY, 2018, 31 (05): : 572 - 582
  • [28] Safety and efficacy of vedolizumab in the treatment of patients with moderate to severe Ulcerative Colitis: a systematic review and meta-analysis
    Khorshid, M.
    Alboraie, M.
    Abbas, W.
    Sayed, Z. E.
    El-Nady, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S516 - S517
  • [29] Effectiveness of adalimumab in severe ulcerative colitis: A systematic review and a meta-analysis
    Azadbakht, Saleh
    Seighali, Masomeh
    Azadbakht, Salehe
    Azadbakht, Morteza
    [J]. HEALTH SCIENCE REPORTS, 2024, 7 (07)
  • [30] Systematic review with meta-analysis: mortality in acute severe ulcerative colitis
    Dong, Catherine
    Metzger, Marie
    Holsbo, Einar
    Perduca, Vittorio
    Carbonnel, Franck
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (01) : 8 - 33